Skip to main content
Home > Week in Review > Sales & Marketing

Chronological Index of : Sales and Marketing

 Current Issue
  • Color Genomics sales and marketing update

    Color Genomics Inc., Burlingame, Calif. Business: Genomics Color Genomics launched its genetic sequencing Color Test that analyzes 19 genes known to have an inherited predisposition for breast and ovarian cancer. The …

    Published on 5/18/2015
  • Veracyte sales and marketing update

    Veracyte Inc. (NASDAQ:VCYT), South San Francisco, Calif. Business: Diagnostic Veracyte launched the Percepta Bronchial Genomic Classifier in the U.S. to resolve ambiguity in lung cancer diagnosis. The 23-gene molecular …

    Published on 5/18/2015
  • Celltrion, Hospira, J&J, Merck, Orion sales and marketing update

    Celltrion Inc. (KOSDAQ:068270), Incheon, South Korea Hospira Inc. (NYSE:HSP), Lake Forest, Ill. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J. Orion Corp. (HSE…

    Published on 5/11/2015
  • Novo Nordisk sales and marketing update

    Novo Nordisk A/S (CSE:NVO; NYSE:NVO), Bagsvaerd, Denmark Business: Hematology Novo Nordisk launched Novoeight turoctocog alfa in the U.S. to treat hemophilia A. The recommended dosage of the third-generation IV …

    Published on 5/11/2015
  • uniQure, Chiesi sales and marketing update

    uniQure N.V. (NASDAQ:QURE), Amsterdam, the Netherlands Chiesi Farmaceutici S.p.A., Parma, Italy Business: Endocrine/Metabolic EMAs Committee for Advanced Therapies (CAT) said it did not agree with a rapporteurs …

    Published on 5/11/2015
  • Viiv Healthcare sales and marketing update

    ViiV Healthcare Ltd., Brentford, U.K. Business: Infectious ViiV announced the launch of Triumeq dolutegravir/abacavir/lamivudine in Japan to treat HIV infection. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK, London, U.K.) …

    Published on 5/11/2015
  • Basilea, Astellas sales and marketing update

    Basilea Pharmaceutica AG (SIX:BSLN), Basel, Switzerland Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Business: Infectious Astellas launched Cresemba isavuconazonium in the U.S. to treat invasive aspergillosis and …

    Published on 5/4/2015
  • Courtagen Life Sciences sales and marketing update

    Courtagen Life Sciences Inc., Woburn, Mass. Business: Diagnostic Courtagen launched lysoSEEK, a genetic test that identifies enzymatic deficiencies in 94 genes associated with lysosomal storage disorders from a saliva …

    Published on 5/4/2015
  • Gilead sales and marketing update

    Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. Business: Infectious Gilead said that Harvoni ledipasvir/sofosbuvir will now be reimbursed by provincial drug programs in Canadian provinces and territories, …

    Published on 5/4/2015
  • Intas Pharmaceuticals sales and marketing update

    Intas Pharmaceuticals Ltd., Ahmedabad, India Business: Autoimmune, Biosimilars Intas launched Intacept, a biosimilar of autoimmune Enbrel entanercept, in India. Intas says that Intracept cuts the cost of treatment to …

    Published on 5/4/2015
  • Pathway Genomics sales and marketing update

    Pathway Genomics Corp., San Diego, Calif. Business: Diagnostic Pathway launched cancer tests ColoTrue and LynchSyndromeTrue. ColoTrue detects pathogenic variants in 15 genes associated with colorectal cancer. …

    Published on 5/4/2015
  • Rosetta Genomics, Admera Health sales and marketing update

    Rosetta Genomics Ltd. (NASDAQ:ROSG), Rehovot, Israel Admera Health, South Plainfield, N.J. Business: Cancer Rosetta launched Admeras laboratory developed test (LDT), OncoGxOne to detects alterations in 64 genes …

    Published on 5/4/2015
  • Dendreon sales and marketing update

    Dendreon Corp. (Pink:DNDNQ), Seattle, Wash. Business: Cancer On March 19, Germans Institute for Quality and Efficiency in Health Care (IQWiG) said in an addendum to a January early benefit assessment that Provenge …

    Published on 4/27/2015
  • Medivation, Astellas sales and marketing update

    Medivation Inc. (NASDAQ:MDVN), San Francisco, Calif. Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Business: Cancer Germanys Institute for Quality and Efficiency in Healthcare (IQWiG) said in an assessment that Xtandi…

    Published on 4/27/2015
  • Novo Nordisk sales and marketing update

    Novo Nordisk A/S (CSE:NVO; NYSE:NVO), Bagsvaerd, Denmark Business: Endocrine/Metabolic Novo Nordisk launched Saxenda liraglutide in the U.S. for weight management as an adjunct to diet and exercise in adults with a BMI …

    Published on 4/27/2015
  • Thermo Fisher sales and marketing update

    Thermo Fisher Scientific Inc. (NYSE:TMO), Waltham, Mass. Business: Cancer Thermo Fisher launched its CE-IVD Oncomine Solid Tumour Fusion Transcript Kit in the EU to sequence formalin-fixed, paraffin-embedded (FFPE) …

    Published on 4/27/2015
  • uniQure, Chiesi sales and marketing update

    uniQure N.V. (NASDAQ:QURE), Amsterdam, the Netherlands Chiesi Farmaceutici S.p.A., Parma, Italy Business: Endocrine/Metabolic Germanys Federal Joint Committee (G-BA) suspended assessment of Glybera alipogene tiparvovec …

    Published on 4/27/2015
  • CombiMatrix, InterWest Health LLC sales and marketing update

    CombiMatrix Corp. (NASDAQ:CBMX), Irvine, Calif. InterWest Health LLC, Missoula, Mont. Business: Diagnostic InterWest will cover CombiMatrixs diagnostic laboratory services. InterWest has over 25,000 hospitals, …

    Published on 4/20/2015
  • Critical Diagnostics sales and marketing update

    Critical Diagnostics, San Diego, Calif. Business: Diagnostic Critical Diagnostics launched its Aspect-PLUS ST2 lateral flow immunoassay in the EU and the Asia-Pacific region. The assay measures the level of IL-1 …

    Published on 4/20/2015
  • Recombine Inc., Sequenom sales and marketing update

    Recombine Inc., New York, N.Y. Sequenom Inc. (NASDAQ:SQNM), San Diego, Calif. Business: Diagnostic Sequenom and Recombine launched Sequenoms HerediT Universal genetic screening test in the U.S. The test screens for more…

    Published on 4/20/2015
  • Cancer Genetics sales and marketing update

    Cancer Genetics Inc. (NASDAQ:CGIX), Rutherford, N.J. Business: Diagnostic Cancer Genetics said Americas Choice Provider Network, a national network of healthcare providers, will cover CGIs cancer diagnostic services. …

    Published on 4/13/2015
  • Endo sales and marketing update

    Endo International plc (NASDAQ:ENDP; TSX:ENL), Dublin, Ireland Business: Endocrine/Metabolic Endo launched testosterone replacement therapy Natesto testosterone nasal gel in the U.S. Natesto is a bioadhesive intranasal …

    Published on 4/13/2015
  • Exact Sciences, Tufts Health Plan sales and marketing update

    Exact Sciences Corp. (NASDAQ:EXAS), Madison, Wis. Tufts Health Plan, Watertown, Mass. Business: Cancer Tufts will cover Exacts Cologuard to screen for colon cancer. The test is available to members ages 50 and older who…

    Published on 4/13/2015
  • Merck sales and marketing update

    Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J. Business: Infectious Merck launched Gardasil 9 in Canada to prevent cancers caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52 and 58 in females ages 9-45 and males …

    Published on 4/13/2015
  • Omeros sales and marketing update

    Omeros Corp. (NASDAQ:OMER), Seattle, Wash. Business: Ophthalmic Omeros launched Omidria in the U.S. to maintain intraoperative mydriasis (pupil size) by preventing intraoperative miosis and to reduce postoperative …

    Published on 4/13/2015

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993